| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 4,957 | 3,229 | 5,368 | | Cost of Revenue | 3,705 | 2,312 | 3,173 | | | Gross Profit | 1,252 | 917 | 2,195 | | | Operating Expenses | | Research Development |
-
| 86 | 1,774 | | Selling General and Administrative | 4,548 | 6,207 | 4,487 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (3,296) | (5,376) | (4,066) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 284 | 1,083 | 1,039 | | Earnings Before Interest And Taxes | (3,012) | (4,293) | (3,027) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (3,012) | (4,293) | (3,027) | | Income Tax Expense |
-
|
-
| (275) | | Minority Interest | 50 |
-
|
-
| | | | Net Income From Continuing Ops | (2,962) | (4,293) | (2,752) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,962) | (4,293) | (2,752) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,962) | ($4,293) | ($2,752) |
|
0.83% Nasdaq 
Income Statement
